ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations. (2022)

First Author: Mathioudakis AG
Attributed to:  Trials Methodology Research Partnership funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1183/13993003.02006-2021

PubMed Identifier: 34649975

Publication URI: http://europepmc.org/abstract/MED/34649975

Type: Journal Article/Review

Volume: 59

Parent Publication: The European respiratory journal

Issue: 5

ISSN: 0903-1936